Description
Interference Mix 6
5-100 μg/mL each component in methanol, Cerilliant®
Synonym(s):
Qualitative Interference Mixture
PROPERTIES
grade
analytical standard
form
liquid
composition
Amlodipine besylate, 5 μg/mL (as free base)
Atorvastatin calcium salt, 100 μg/mL (as free base)
Azithromycin dihydrate, 100 μg/mL (as free base)
Bupivacaine hydrochloride monohydrate, 100 μg/mL (as free base)
Cetirizine dihydrochloride, 50 μg/mL (as free base)
Dimenhydrinate, 100 μg/mL
Lisinopril dihydrate, 100 μg/mL (as free base)
Loratadine, 100 μg/mL
packaging
ampule of 1 mL
manufacturer/tradename
Cerilliant®
concentration
5-100 μg/mL each component in methanol
technique(s)
gas chromatography (GC): suitable
liquid chromatography (LC): suitable
application(s)
forensics and toxicology
format
single component solution
storage temp.
−20°C
DESCRIPTION
General description
A multi-component solution standard of routinely monitored over-the-counter (OTC) and prescription drugs amlodipine, atorvastatin, cetirizine, azithromycin, bupivacaine, dimenhydrinate, lisinopril, and loratidine. This standard is for qualitative use only in the evaluation of interferences between the mix components and target analytes of interest in a testing laboratory′s analytical methods.
Legal Information
CERILLIANT is a registered trademark of Cerilliant Corporation
SAFETY INFORMATION
Signal Word
Danger
Hazard Statements
H225 - H301 + H311 + H331 - H370
Precautionary Statements
P210 - P233 - P280 - P301 + P310 - P303 + P361 + P353 - P304 + P340 + P311
Hazard Classifications
Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
Storage Class Code
3 - Flammable liquids
WGK
WGK 2
Flash Point(F)
49.5 °F - closed cup
Flash Point(C)
9.7 °C - closed cup